Mycotic findings in patients after liver transplantation – Invasive mycosis or harmless colonization?

• Conditions: Patients undergoing orthotopic liver transplantation from deceased donors; C22.0; K74.6; Liver cell carcinoma; Other and unspecified cirrhosis of liver

• Registration Number: DRKS00005480
• Lead Sponsor: Klinik für Anaesthesiologie Universitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11-26
• Study Completion: 2016-03-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 93

Inclusion Criteria

•Liver transplantation at the center of transplantation in Heidelberg
•Written and signed informt consens
•Age > 18 years

Exclusion Criteria

Non-Compliance to the including criteria’s

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence, risk factors and progress of mycotic infections in patients with liver transplantation. <br><br>

Secondary Outcome Measures

Name	Time	Method
Assessment of the additional benefit of a next-generation sequencing (NGS)-based diagnostic approach, the diagnostic value of ß-D-glucan (BG), galactomannan (GM), interferon gamma (INF-?), tumor necrosis factor alpha (TNF-a), interleukins (IL)-2, -4, -6, -10, -17A and mid-regional proadrenomedullin (MR-proADM) for the diagnosis of an invasive fungal disease